FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Chris Hyde

Research Profile

Concepts & Ideas

Activities & Behaviors

Cost Benefit Analysis

Geographic Areas

Great Britain

Procedures

Occupations

Evidence-Based Medicine

Chemicals & Drugs

Disorders

Hemorrhage

Physiology

Pregnancy

Co-author Network

Publications

TOP 3
Martin Hoyle; C Cooper; L Crathorne; T Jones-Hughes; M Napier; J Peters; P Tappenden; Chris Hyde
The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisal No.150 and part review of technology appraisal No. 118): a systematic review and economic model.
Jaime L Peters; Rob Anderson; Martin Hoyle; Chris Hyde
Evolution of a cost-utility model of donepezil for Alzheimer's disease.
Mary Bond; C Cooper; S Dean; Ruth Garside; T Pavey; K Welch; Chris Hyde
Systematic review of the psychological consequences of false-positive screening mammograms.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Chris Hyde (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Martin Hoyle; C Cooper; L Crathorne; T Jones-Hughes; M Napier; J Peters; P Tappenden; Chris Hyde
The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisal No.150 and part review of technology appraisal No. 118): a systematic review and economic model.
Health technology assessment (Winchester, England) 2013;17(14):1-237.
2013: Jaime L Peters; Rob Anderson; Martin Hoyle; Chris Hyde
Evolution of a cost-utility model of donepezil for Alzheimer's disease.
International journal of technology assessment in health care 2013;29(2):147-54.
2013: Mary Bond; C Cooper; S Dean; Ruth Garside; T Pavey; K Welch; Chris Hyde
Systematic review of the psychological consequences of false-positive screening mammograms.
Health technology assessment (Winchester, England) 2013;17(13):1-170, v-vi.
2013: Martin Hoyle; Chris Cooper; Louise Crathorne; Tracey Jones-Hughes; Mark Napier; Jaime Peters; Chris Hyde
Cost-effectiveness of cetuximab, cetuximab plus irinotecan, and panitumumab for third and further lines of treatment for KRAS wild-type patients with metastatic colorectal cancer.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2013;16(2):288-96.
2013: Sally Hopewell; Chris Hyde; Omar Omar; Ly-Mee Yu; Carolyn Doree; Mike F Murphy
A systematic review of the effect of red blood cell transfusion on mortality: evidence from large-scale observational studies published between 2006 and 2010.
BMJ open 2013;3(5):.
2013: Chris Hyde; Mike Jeffreys; Jaime Peters; Gabriel Rogers; Praveen Thokala; Rob Anderson; Mary Bond; Sarah Davis; Martin Hoyle; Tiffany Moxham
Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model.
Age and ageing 2013;42(1):14-20.
2012: Lavinia Ferrante di Ruffano; Chris Hyde; Clare Davenport; Anne Eisinga; Jonathan J Deeks
A capture-recapture analysis demonstrated that randomized controlled trials evaluating the impact of diagnostic tests on patient outcomes are rare.
Journal of clinical epidemiology 2012;65(3):282-7.
2012: Beverley M Shields; Chris Cooper; Chris Hyde; Bridget A Knight; Jaime L Peters; Roy J Powell; Andrew T Hattersley
Identifying clinical criteria to predict Type 1 diabetes, as defined by absolute insulin deficiency: a systematic review protocol.
BMJ open 2012;2(6):.
2012: Thomy Tonia; Olaf Weingart; Andreas Engert; Chris Hyde; Annette Mettler; Nadège Robert; Guido Schwarzer; Jerome Seidenfeld; Julia Bohlius
Erythropoietin or darbepoetin for patients with cancer.
Cochrane database of systematic reviews (Online) 2012;12():CD003407.
2012: Mary Bond; S Davis; Martin Hoyle; M Jeffreys; A Miners; T Moxham; J Peters; Gabriel Rogers; P Thokala; A Wailoo; Rob Anderson; Chris Hyde
The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.
Health technology assessment (Winchester, England) 2012;16(21):1-470.
2012: Ewurabena Simpson; Simon Stanworth; Janet Birchall; Carolyn Doree; Yulia Lin; Chris Hyde
Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.
Cochrane database of systematic reviews (Online) 2012;3():CD005011.
2011: Martin Connock; Chris Hyde; David Moore
Cautions regarding the fitting and interpretation of survival curves: examples from NICE single technology appraisals of drugs for cancer.
PharmacoEconomics 2011;29(10):827-37.
2011: P Auguste; Pelham M Barton; Chris Hyde; T E Roberts
An economic evaluation of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence.
Health technology assessment (Winchester, England) 2011;15(18):iii-iv, 1-54.
2010: K Ashfaq; I Yahaya; Chris Hyde; L Andronis; Pelham M Barton; Sue Bayliss; Yen Fu Chen
Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review.
Health technology assessment (Winchester, England) 2010;14(54):iii-iv, ix-xi, 1-141.
2010: Martin Pitt; L Crathorne; T Moxham; Mary Bond; Chris Hyde
Everolimus for the second-line treatment of advanced and/or metastatic renal cell cancer: a critique of the submission from Novartis.
Health technology assessment (Winchester, England) 2010;14(Suppl. 2):41-6.
2010: M Pennant; Y Takwoingi; L Pennant; Clare Davenport; Anne Fry-Smith; A Eisinga; L Andronis; Theodoros Arvanitis; J Deeks; Chris Hyde
A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence.
Health technology assessment (Winchester, England) 2010;14(50):1-103.
2010: Carolyn Dorée; Simon Stanworth; Susan Brunskill; Sally Hopewell; Chris Hyde; Mike F Murphy
Where are the systematic reviews in transfusion medicine? A study of the transfusion evidence base.
Transfusion medicine reviews 2010;24(4):286-94.
2010: R Edlin; Martin Connock; S Tubeuf; J Round; Anne Fry-Smith; Chris Hyde; W Greenheld
Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia.
Health technology assessment (Winchester, England) 2010;14 Suppl 1():69-74.
2010: Stirling Bryan; L Andronis; Chris Hyde; Martin Connock; Anne Fry-Smith; D Wang
Infliximab for the treatment of acute exacerbations of ulcerative colitis.
Health technology assessment (Winchester, England) 2010;14 Suppl 1():9-15.
2010: Vipul Jairath; Sarah Hearnshaw; Susan Brunskill; Carolyn Doree; Sally Hopewell; Chris Hyde; Simon Travis; Michael F Murphy
Red cell transfusion for the management of upper gastrointestinal haemorrhage.
Cochrane database of systematic reviews (Online) 2010;(9):CD006613.
2009: Jill J Francis; Charlotte Stockton; Martin P Eccles; Marie Johnston; Brian H Cuthbertson; Jeremy Grimshaw; Chris Hyde; Alan Tinmouth; Simon J Stanworth
Evidence-based selection of theories for designing behaviour change interventions: using methods based on theoretical construct domains to understand clinicians' blood transfusion behaviour.
British journal of health psychology 2009;14(Pt 4):625-46.
2009: Yen Fu Chen; Sue Jowett; Pelham M Barton; K Malottki; Chris Hyde; J S R Gibbs; J Pepke-Zaba; Anne Fry-Smith; J Roberts; David Moore
Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation.
Health technology assessment (Winchester, England) 2009;13(49):1-320.
2009: Chris Hyde; Stirling Bryan; Ariadna Juarez-Garcia; L Andronis; Anne Fry-Smith
Infliximab for the treatment of ulcerative colitis.
Health technology assessment (Winchester, England) 2009;13 Suppl 3():7-11.
2009: Derwood Pamphilon; Samreen Siddiq; Susan Brunskill; Carolyn Dorée; Chris Hyde; Mary Horowitz; Simon Stanworth
Stem cell donation--what advice can be given to the donor?
British journal of haematology 2009;147(1):71-6.
2009: Susan Brunskill; Chris Hyde; Carolyn Doree; Suzanne M Watt; Enca Martin-Rendon
Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease.
European journal of heart failure 2009;11(9):887-96.
2009: Susan Brunskill; Chris Hyde; Simon Stanworth; C J Dorée; DJ Roberts; Michael F Murphy
Improving the evidence base for transfusion medicine: the work of the UK systematic review initiative.
Transfusion medicine (Oxford, England) 2009;19(2):59-65.
2009: Angelos Tsourapas; Tracy E Roberts; Pelham M Barton; Honest Honest; Carol Forbes; Chris Hyde; Khalid S Khan
An economic evaluation of alternative test-intervention strategies to prevent spontaneous pre-term birth in singleton pregnancies.
Acta obstetricia et gynecologica Scandinavica 2009;88(12):1319-30.
2009: Jill Francis; Alan Tinmouth; Simon J Stanworth; Jeremy Grimshaw; Marie Johnston; Chris Hyde; Charlotte Stockton; Jamie C Brehaut; Dean Fergusson; Martin P Eccles
Using theories of behaviour to understand transfusion prescribing in three clinical contexts in two countries: development work for an implementation trial.
Implementation science : IS 2009;4():70.
2009: Timothy N Board; Susan Brunskill; Carolyn Doree; Chris Hyde; Peter R Kay; Rm Dominic Meek; Robert Webster; George Galea
Processed versus fresh frozen bone for impaction bone grafting in revision hip arthroplasty.
Cochrane database of systematic reviews (Online) 2009;(4):CD006351.
2009: Jeltsje S Cnossen; Gerben ter Riet; Ben W J Mol; Joris A M van der Post; Mariska Leeflang; Catherine Meads; Chris Hyde; Khalid S Khan
Are tests for predicting pre-eclampsia good enough to make screening viable? A review of reviews and critical appraisal.
Acta obstetricia et gynecologica Scandinavica 2009;88(7):758-65.
2009: Sarah Hearnshaw; Susan Brunskill; Carolyn Doree; Chris Hyde; Simon Travis; Michael F Murphy
Red cell transfusion for the management of upper gastrointestinal haemorrhage.
Cochrane database of systematic reviews (Online) 2009;(2):CD006613.
2009: Janine Dretzke; Clare Davenport; Emma Frew; Jane Barlow; Sarah Stewart-Brown; Sue Bayliss; Rod S Taylor; Josie Sandercock; Chris Hyde
The clinical effectiveness of different parenting programmes for children with conduct problems: a systematic review of randomised controlled trials.
Child and adolescent psychiatry and mental health 2009;3(1):7.
2009: Samreen Siddiq; Derwood Pamphilon; Susan Brunskill; Carolyn Doree; Chris Hyde; Simon Stanworth
Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors.
Cochrane database of systematic reviews (Online) 2009;(1):CD006406.
2008: M A Silva; B Hegab; Chris Hyde; B Guo; J A C Buckels; D F Mirza
Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis.
Gut 2008;57(11):1592-6.
2008: Enca Martin-Rendon; Susan J Brunskill; Chris Hyde; Simon Stanworth; Anthony Mathur; Suzanne M Watt
Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review.
European heart journal 2008;29(15):1807-18.
2008: Janet Birchall; Simon J Stanworth; Michael R Duffy; Carolyn Doree; Chris Hyde
Evidence for the use of recombinant factor VIIa in the prevention and treatment of bleeding in patients without hemophilia.
Transfusion medicine reviews 2008;22(3):177-87.
2008: Chris Hyde; Simon Stanworth; Michael F Murphy
Can you see the wood for the trees? Making sense of forest plots in systematic reviews 2. Analysis of the combined results from the included studies.
Transfusion 2008;48(4):580-3.
2008: Catherine Meads; J S Cnossen; S Meher; Ariadna Juarez-Garcia; Gerben ter Riet; L Duley; Tracy E Roberts; Ben W J Mol; Joris van der Post; Mariska Leeflang; Pelham M Barton; Chris Hyde; Janesh K Gupta; Khalid S Khan
Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling.
Health technology assessment (Winchester, England) 2008;12(6):iii-iv, 1-270.
2008: Chris Hyde; Simon Stanworth; Michael F Murphy
Can you see the wood for the trees? Making sense of forest plots in systematic reviews.
Transfusion 2008;48(2):218-20.
2008: Enca Martin-Rendon; Susan Brunskill; Carolyn Dorée; Chris Hyde; Suzanne Watt; Anthony Mathur; Simon Stanworth
Stem cell treatment for acute myocardial infarction.
Cochrane database of systematic reviews (Online) 2008;(4):CD006536.
2008: Jonathan Roberts; Aarnoud Huissoon; Janine Dretzke; Dechao Wang; Chris Hyde
A systematic review of the clinical effectiveness of acupuncture for allergic rhinitis.
BMC complementary and alternative medicine 2008;8():13.
2007: Simon Stanworth; Chris Hyde; Michael F Murphy
Evidence for indications of fresh frozen plasma.
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2007;14(6):551-6.
2007: P Wood; Simon Stanworth; J Burton; A Jones; D G Peckham; T Green; Chris Hyde; H Chapel
Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review.
Clinical and experimental immunology 2007;149(3):410-23.
2007: Jayne Wilson; Guiqing L Yao; James Raftery; Julia Bohlius; Susan Brunskill; Josie Sandercock; Sue Bayliss; Paul Moss; Simon Stanworth; Chris Hyde
A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.
Health technology assessment (Winchester, England) 2007;11(13):1-202, iii-iv.
2007: DJ Roberts; Susan Brunskill; Carolyn Doree; S Williams; J Howard; Chris Hyde
Oral deferiprone for iron chelation in people with thalassaemia.
Cochrane database of systematic reviews (Online) 2007;(3):CD004839.
2007: Simon Stanworth; J Birchall; Carolyn Doree; Chris Hyde
Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.
Cochrane database of systematic reviews (Online) 2007;(2):CD005011.
2006: Julia Bohlius; Jayne Wilson; Jerome Seidenfeld; Margaret Piper; Guido Schwarzer; Josie Sandercock; Sven Trelle; Olaf Weingart; Sue Bayliss; Benjamin Djulbegovic; Charles L Bennett; Simon Langensiepen; Chris Hyde; Andreas Engert
Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.
Journal of the National Cancer Institute 2006;98(10):708-14.
2006: Julia Bohlius; Jayne Wilson; Jerome Seidenfeld; Margaret Piper; Guido Schwarzer; Josie Sandercock; Sven Trelle; Olaf Weingart; Sue Bayliss; Susan Brunskill; Benjamin Djulbegovic; C L Benett; Simon Langensiepen; Chris Hyde; E Engert
Erythropoietin or darbepoetin for patients with cancer.
Cochrane database of systematic reviews (Online) 2006;(3):CD003407.
2006: Catherine Meads; Chris Hyde
How much is the cost of visual impairment: caveat emptor.
PharmacoEconomics 2006;24(2):207-9; discussion 210.
2006: Clare Davenport; Elaine Yee Lan Cheng; Yip Tung Tony Kwok; Annie Hiu On Lai; Taka Wakabayashi; Chris Hyde; Martin Connock
Assessing the diagnostic test accuracy of natriuretic peptides and ECG in the diagnosis of left ventricular systolic dysfunction: a systematic review and meta-analysis.
The British journal of general practice : the journal of the Royal College of General Practitioners 2006;56(522):48-56.
2006: Simon Stanworth; Susan Brunskill; Chris Hyde; Michael F Murphy; D B L McClelland
Appraisal of the evidence for the clinical use of FFP and plasma fractions.
Best practice & research. Clinical haematology 2006;19(1):67-82.
2005: Simon Stanworth; Chris Hyde; Susan Brunskill; Michael F Murphy
Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?
British journal of haematology 2005;131(5):588-95.
2005: Janine Dretzke; Emma J Frew; Clare Davenport; J Barlow; Sarah Stewart-Brown; Josie Sandercock; Sue Bayliss; James Raftery; Chris Hyde; Rod S Taylor
The effectiveness and cost-effectiveness of parent training/education programmes for the treatment of conduct disorder, including oppositional defiant disorder, in children.
Health technology assessment (Winchester, England) 2005;9(50):iii, ix-x, 1-233.
2005: Chris Hyde; Simon Stanworth; Susan Brunskill; Michael Murphy
Putting clinical trials into context.
Lancet 2005;366(9490):980-1.
2005: B H Willis; Pelham M Barton; P Pearmain; Stirling Bryan; Chris Hyde
Cervical screening programmes: can automation help? Evidence from systematic reviews, an economic analysis and a simulation modelling exercise applied to the UK.
Health technology assessment (Winchester, England) 2005;9(13):1-207, iii.
2005: DJ Roberts; D Rees; J Howard; Chris Hyde; P Alderson; Susan Brunskill
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.
Cochrane database of systematic reviews (Online) 2005;(4):CD004450.
2005: Simon Stanworth; E Massey; Chris Hyde; Susan Brunskill; G Lucas; C Navarrete; D I Marks
Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction.
Cochrane database of systematic reviews (Online) 2005;(3):CD005339.
2004: Fujian Song; Anne Fry-Smith; Clare Davenport; Sue Bayliss; Yaser Adi; J S Wilson; Chris Hyde
Identification and assessment of ongoing trials in health technology assessment reviews.
Health technology assessment (Winchester, England) 2004;8(44):iii, 1-87.
2004: Simon Stanworth; Susan Brunskill; Chris Hyde; D B L McClelland; Michael F Murphy
Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials.
British journal of haematology 2004;126(1):139-52.
2004: Catherine Meads; Chris Hyde
Photodynamic therapy with verteporfin is effective, but how big is its effect? Results of a systematic review.
The British journal of ophthalmology 2004;88(2):212-7.
2004: Simon Stanworth; Chris Hyde; N Heddle; Paolo Rebulla; Susan Brunskill; Michael F Murphy
Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
Cochrane database of systematic reviews (Online) 2004;(4):CD004269.
2004: Sue Simpson; Chris Hyde; Alison Cook; Claire Packer; Andrew J Stevens
Assessing the accuracy of forecasting: applying standard diagnostic assessment tools to a health technology early warning system.
International journal of technology assessment in health care 2004;20(3):381-4.
2003: Catherine Meads; Chris Hyde
What is the cost of blindness?
The British journal of ophthalmology 2003;87(10):1201-4.
2003: Chris Hyde; Janine Dretzke
Combined salmeterol and fluticasone for COPD.
Lancet 2003;361(9369):1652; author reply 1652-3.
2003: Catherine Meads; C Salas; Tracy Roberts; David Moore; Anne Fry-Smith; Chris Hyde
Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation.
Health technology assessment (Winchester, England) 2003;7(9):v-vi, 1-98.
2002: T Justin Clark; Doris Voit; Janesh K Gupta; Chris Hyde; Fujian Song; Khalid S Khan
Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review.
JAMA : the journal of the American Medical Association 2002;288(13):1610-21.
2002: Fujian Song; James Raftery; Paul Aveyard; Chris Hyde; Pelham M Barton; Nerys F Woolacott
Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis.
Medical decision making : an international journal of the Society for Medical Decision Making 2002;22(5 Suppl):S26-37.
2002: Rachel Jordan; Lisa Gold; Carole Cummins; Chris Hyde
Systematic review and meta-analysis of evidence for increasing numbers of drugs in antiretroviral combination therapy.
BMJ (Clinical research ed.) 2002;324(7340):757.
2002: Yaser Adi; D Ashcroft; Kevin Browne; Anthony R Beech; Anne Fry-Smith; Chris Hyde
Clinical effectiveness and cost-consequences of selective serotonin reuptake inhibitors in the treatment of sex offenders.
Health technology assessment (Winchester, England) 2002;6(28):1-66.
2002: Nerys F Woolacott; Lisa Jones; Carol Forbes; Lisa Mather; Amanda J Sowden; Fujian Song; J P Raftery; P N Aveyard; Chris Hyde; Pelham M Barton
The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation.
Health technology assessment (Winchester, England) 2002;6(16):1-245.
2002: Chris Hyde; Beverley Wake; Stirling Bryan; Pelham M Barton; Anne Fry-Smith; Clare Davenport; Fujian Song
Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment.
Health technology assessment (Winchester, England) 2002;6(2):1-89.
2002: Beverley Wake; Chris Hyde; Stirling Bryan; Pelham M Barton; Fujian Song; Anne Fry-Smith; Clare Davenport
Rituximab as third-line treatment for refractory or recurrent Stage III or IV follicular non-Hodgkin's lymphoma: a systematic review and economic evaluation.
Health technology assessment (Winchester, England) 2002;6(3):1-85.
2001: IE Robert; Chris Hyde; S A Bridgman
Orthopaedic fractures: trends in randomised controlled trials.
Injury 2001;32(10):779-82.
2001: J Middleton; E Reeves; R Lifford; F Howie; Chris Hyde
Collaboration with the Campbell collaboration. The Campbell principles are applied in West Midlands through public health research forum.
BMJ (Clinical research ed.) 2001;323(7323):1252-3.
2001: Josie Sandercock; Amanda Burls; Chris Hyde; Anne Fry-Smith; Pelham M Barton; Stirling Bryan; A Stewart
Riluzole for motor neurone disease. More trials are needed.
BMJ (Clinical research ed.) 2001;322(7297):1305.
2001: A Stewart; Josie Sandercock; Stirling Bryan; Chris Hyde; Pelham M Barton; Anne Fry-Smith; Amanda Burls
The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review.
Health technology assessment (Winchester, England) 2001;5(2):1-97.
2000: Chris Hyde; IE Robert; AJ Sinclair
The effects of supporting discharge from hospital to home in older people.
Age and ageing 2000;29(3):271-9.
2000: Awoniyi Awonuga; LS Dwarakanath; Richard B Johanson; Chris Hyde; Rod S Taylor; Khalid S Khan
Critical appraisal workshops to promote evidence-based healthcare.
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 2000;20(1):10-4.
2000: Pedro M Brañas Tato; R Jordan; Anne Fry-Smith; Amanda Burls; Chris Hyde
Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
Health technology assessment (Winchester, England) 2000;4(27):1-61.
2000: Catherine Meads; Carole Cummins; Kate Jolly; Andrew J Stevens; Amanda Burls; Chris Hyde
Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.
Health technology assessment (Winchester, England) 2000;4(23):1-153.
2000: Brendan Delaney; Sue Wilson; David Fitzmaurice; Chris Hyde; Richard F D Hobbs
Near-patient tests in primary care: setting the standards for evaluation.
Journal of health services research & policy 2000;5(1):37-41.
1999: Brendan Delaney; Chris Hyde; Richard J McManus; Sue Wilson; David Fitzmaurice; Sue Jowett; Rosalind S Tobias; GH Thorpe; F D Richard Hobbs
Systematic review of near patient test evaluations in primary care.
BMJ (Clinical research ed.) 1999;319(7213):824-7.
1999: J Young; Anne Fry-Smith; Chris Hyde
Lung volume reduction surgery (LVRS) for chronic obstructive pulmonary disease (COPD) with underlying severe emphysema.
Thorax 1999;54(9):779-89.
1998: Richard J McManus; Sue Wilson; Brendan Delaney; David Fitzmaurice; Chris Hyde; Rosalind S Tobias; Sue Jowett; F D Richard Hobbs
Review of the usefulness of contacting other experts when conducting a literature search for systematic reviews.
BMJ (Clinical research ed.) 1998;317(7172):1562-3.
1997: J E Powell; Chris Hyde
Diagnosis of intracranial injury.
Lancet 1997;349(9065):1627-8.
1997: F D Richard Hobbs; Brendan Delaney; David Fitzmaurice; Sue Wilson; Chris Hyde; GH Thorpe; AS Earl-Slater; Sue Jowett; Rosalind S Tobias
A review of near patient testing in primary care.
Health technology assessment (Winchester, England) 1997;1(5):i-iv, 1-229.
1996: Chris Hyde; A Fry-Smith
Preterm premature rupture of membranes.
Lancet 1996;347(8995):203.